Does MPN Change the Outlook After Splanchnic Vein Thrombosis? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Amica K Ko et al., adding:
“Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Does a myeloproliferative neoplasm change the outlook after splanchnic vein thrombosis?
In this large cohort, rates of recurrent thrombosis, bleeding, and survival at six months were similar whether or not patients had an MPN.
The authors suggest MPN-related splanchnic vein thrombosis can be managed much like noncirrhotic, nonmalignant disease, while longer prospective follow-up is still needed.”
Title: Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Authors: Amica K Ko, Laura Milana, Nicoletta Riva, Lorenza Bertu, Laurent Bertoletti, Jan Beyer-Westendorf, Marc Carrier, Aurelien Delluc, Elvira Grandone, Pieter Kamphuisen, Alejandro Lazo-Langner, Margherita Maffioli, Daniela Poli, Sam Schulman, Marco Senzolo, Sophie Testa, Alberto Tosetto, Peter Verhamme, Frank W G Leebeek, Sarwa Darwish Murad, Walter Ageno, Mandy N Lauw
Other articles about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Jul 8, 2026, 16:09Abdulrahman Katib: New Leadership for Better VTE Care
-
Jul 8, 2026, 16:01Marianne Yee: The Results of RBC Transfusion Survival Studies
-
Jul 8, 2026, 15:59Shadi Tabibian։ Women and Girls with Hemophilia Should Not Be Invisible in Hemophilia Care
-
Jul 8, 2026, 14:17Maha Othman: Advancing Thrombosis and Hemostasis Research at ISTH 2026
-
Jul 8, 2026, 14:07Zain Khalpey: Atrial Fibrillation as the Hidden Driver of Preventable Ischemic Stroke
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia